Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study.
van der Valk MJM, Hilling DE, Bastiaannet E, Meershoek-Klein Kranenbarg E, Beets GL, Figueiredo NL, Habr-Gama A, Perez RO, Renehan AG, van de Velde CJH; IWWD Consortium. van der Valk MJM, et al. Lancet. 2018 Jun 23;391(10139):2537-2545. doi: 10.1016/S0140-6736(18)31078-X. Lancet. 2018. PMID: 29976470 Free article.
Improvement of staging by combining tumor and treatment parameters: the value for prognostication in rectal cancer.
Gosens MJ, van Krieken JH, Marijnen CA, Meershoek-Klein Kranenbarg E, Putter H, Rutten HJ, Bujko K, van de Velde CJ, Nagtegaal ID; Cooperative Clinical Investigators and the Pathology Review Committee. Gosens MJ, et al. Clin Gastroenterol Hepatol. 2007 Aug;5(8):997-1003. doi: 10.1016/j.cgh.2007.03.016. Epub 2007 Jun 4. Clin Gastroenterol Hepatol. 2007. PMID: 17544876 Clinical Trial.
Efficacy of six month neoadjuvant endocrine therapy in postmenopausal, hormone receptor-positive breast cancer patients--a phase II trial.
Fontein DB, Charehbili A, Nortier JW, Meershoek-Klein Kranenbarg E, Kroep JR, Putter H, van Riet Y, Nieuwenhuijzen GA, de Valk B, Terwogt JM, Algie GD, Liefers GJ, Linn S, van de Velde CJ. Fontein DB, et al. Eur J Cancer. 2014 Sep;50(13):2190-200. doi: 10.1016/j.ejca.2014.05.010. Epub 2014 Jun 23. Eur J Cancer. 2014. PMID: 24970786 Clinical Trial.
No Increased Risk of Second Cancer After Radiotherapy in Patients Treated for Rectal or Endometrial Cancer in the Randomized TME, PORTEC-1, and PORTEC-2 Trials.
Wiltink LM, Nout RA, Fiocco M, Meershoek-Klein Kranenbarg E, Jürgenliemk-Schulz IM, Jobsen JJ, Nagtegaal ID, Rutten HJ, van de Velde CJ, Creutzberg CL, Marijnen CA. Wiltink LM, et al. J Clin Oncol. 2015 May 20;33(15):1640-6. doi: 10.1200/JCO.2014.58.6693. Epub 2014 Dec 22. J Clin Oncol. 2015. PMID: 25534376
Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05).
Blok EJ, Kroep JR, Meershoek-Klein Kranenbarg E, Duijm-de Carpentier M, Putter H, van den Bosch J, Maartense E, van Leeuwen-Stok AE, Liefers GJ, Nortier JWR, Rutgers EJT, van de Velde CJH; IDEAL Study Group. Blok EJ, et al. J Natl Cancer Inst. 2018 Jan 1;110(1). doi: 10.1093/jnci/djx134. J Natl Cancer Inst. 2018. PMID: 28922787 Clinical Trial.
62 results